Abbott Laboratories
ABT
Common Stock
$113.76
Sector: Health Care
Industry: Health Care Equipment & Supplies
Sub-Industry: Health Care Equipment
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 |
Sales/Revenue | $43.08 B | $34.61 B | $31.90 B | $30.58 B | $27.39 B |
Sales Growth | 24.47% | 8.48% | 4.34% | 11.64% | 0.00% |
Gross Margin | +53.89 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | $7.04 B | $4.45 B | $3.67 B | $2.32 B | $344.00 M |
Net Income Growth | 58.28% | 21.36% | 58.09% | 574.13% | 0.00% |
Net Margin | +16.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | $12.74 B | $8.62 B | $7.61 B | $7.12 B | $4.99 B |
Cost of Goods Sold (incl D&A) | $19.86 B | $17.23 B | $15.21 B | $14.76 B | $14.32 B |
Cost of Goods Sold (excl D&A) | $16.32 B | $13.90 B | $12.20 B | $11.48 B | $11.30 B |
Cost of Goods Growth | 15.26% | 13.28% | 3.09% | 3.01% | 0.00% |
Research & Development | $2.74 B | $2.42 B | $2.41 B | $2.29 B | $2.13 B |
Other SG&A Expenses | $0.00 M | $9.67 B | $9.69 B | $9.69 B | $8.96 B |
Interest Expense | $410.00 M | $708.00 M | $818.00 M | $729.00 M | $880.00 M |
Income Tax | $1.14 B | $497.00 M | $390.00 M | $539.00 M | $1.88 B |
2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | $0.81 | $1.14 | $1.37 | $1.11 |
Sales/Revenue | $10.41 B | $11.26 B | $11.90 B | $11.47 B |
Sales Growth | -7.52% | -5.36% | 3.72% | 4.94% |
Gross Margin | +53.89 | 0.00 | 0.00 | 0.00 |
Net Income | $1.43 B | $2.01 B | $2.44 B | $1.98 B |
Net Income Growth | -28.87% | -17.60% | 23.07% | -5.31% |
Net Margin | +16.35 | 0.00 | 0.00 | 0.00 |
EBITDA | $2.52 B | $3.16 B | $3.71 B | $3.33 B |
Cost of Goods Sold (incl D&A) | $5.20 B | $5.48 B | $5.53 B | $5.26 B |
Cost of Goods Sold (excl D&A) | $4.39 B | $4.66 B | $4.70 B | $4.38 B |
Cost of Goods Growth | -5.14% | -0.78% | 5.08% | 8.03% |
Research & Development | $780.00 M | $684.00 M | $697.00 M | $758.00 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Interest Expense | $56.00 M | $85.00 M | $10.00 M | $89.00 M |
Income Tax | $323.00 M | $334.00 M | $429.00 M | $338.00 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $10.11 B | $10.13 B | $8.97 B | $7.56 B | $7.61 B |
Cash and Short-Term Investment | $10.25 B | $7.15 B | $4.14 B | $4.09 B | $9.61 B |
Cash and Short-Term Investment Growth | 43.38% | 72.66% | 1.32% | -57.48% | 0.00% |
Long Term Debt | $18.25 B | $19.43 B | $17.42 B | $19.36 B | $27.21 B |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.01 M | $0.01 M | $0.01 M | $0.01 M | $0.01 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $75.20 B | $72.55 B | $67.89 B | $67.17 B | $76.25 B |
Total Assets Growth | 3.65% | 6.87% | 1.06% | -11.90% | 0.00% |
Inventories | $5.16 B | $5.01 B | $4.32 B | $3.80 B | $3.60 B |
Finished Goods | $3.08 B | $3.03 B | $2.78 B | $2.41 B | $2.34 B |
Short Term Debt | $999.00 M | $461.00 M | $1.68 B | $207.00 M | $714.00 M |
Total Liabilities | $39.17 B | $39.55 B | $36.59 B | $36.45 B | $45.15 B |
2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $8.69 B | $8.82 B | $8.91 B | $10.11 B | $8.83 B |
Cash and Short-Term Investment | $9.91 B | $9.29 B | $8.16 B | $10.25 B | $9.69 B |
Cash and Short-Term Investment Growth | 6.64% | 13.88% | -20.40% | 5.75% | 0.00% |
Long Term Debt | $15.30 B | $16.76 B | $17.09 B | $18.25 B | $17.45 B |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.01 M | $0.01 M | $0.01 M | $0.01 M | $0.01 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $72.80 B | $74.20 B | $74.01 B | $75.20 B | $73.80 B |
Total Assets Growth | -1.89% | 0.26% | -1.58% | 1.90% | 0.00% |
Inventories | $5.73 B | $5.90 B | $5.69 B | $5.16 B | $5.26 B |
Finished Goods | $3.41 B | $3.57 B | $3.47 B | $3.08 B | $3.05 B |
Short Term Debt | $1.12 B | $5.00 M | $4.00 M | $999.00 M | $951.00 M |
Total Liabilities | $36.92 B | $37.49 B | $38.38 B | $39.17 B | $39.16 B |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|---|---|
2024-08-16 | 3.21 | $421.50 K |
2024-09-20 | 0.6 | $287.30 K |
2025-01-17 | 1.1 | $21.61 M |
Quarter | Amount | Yield |
---|---|---|
2023 Q4
|
$0.55
|
1.90%
|
2023 Q3
|
$0.51
|
2.30%
|
2023 Q2
|
$0.51
|
1.90%
|
2023 Q1
|
$0.51
|
2.00%
|
2022 Q4
|
$0.51
|
1.80%
|
2022 Q3
|
$0.47
|
1.80%
|
2022 Q2
|
$0.47
|
1.80%
|
2022 Q1
|
$0.47
|
1.60%
|
2021 Q4
|
$0.47
|
1.50%
|
2021 Q3
|
$0.45
|
1.50%
|
2021 Q2
|
$0.45
|
1.50%
|
2021 Q1
|
$0.45
|
1.50%
|
2020 Q4
|
$0.45
|
1.60%
|
2020 Q3
|
$0.36
|
1.30%
|
2020 Q2
|
$0.36
|
1.50%
|
2020 Q1
|
$0.36
|
1.60%
|
2019 Q4
|
$0.36
|
1.70%
|
2019 Q3
|
$0.32
|
1.60%
|
2019 Q2
|
$0.32
|
1.50%
|
2019 Q1
|
$0.32
|
1.60%
|
2018 Q4
|
$0.32
|
1.90%
|
2018 Q3
|
$0.28
|
1.60%
|
2018 Q2
|
$0.28
|
1.80%
|
2018 Q1
|
$0.28
|
1.90%
|
2017 Q4
|
$0.28
|
1.90%
|
2017 Q3
|
$0.27
|
1.90%
|
2017 Q2
|
$0.27
|
2.20%
|
2017 Q1
|
$0.27
|
2.40%
|
2016 Q4
|
$0.27
|
2.60%
|
2016 Q3
|
$0.26
|
2.50%
|
2016 Q2
|
$0.26
|
2.50%
|
2016 Q1
|
$0.26
|
2.40%
|
2015 Q4
|
$0.26
|
2.60%
|
2015 Q3
|
$0.24
|
2.30%
|
2015 Q2
|
$0.24
|
1.90%
|
2015 Q1
|
$0.24
|
2.10%
|
2014 Q4
|
$0.24
|
2.20%
|
2014 Q3
|
$0.22
|
2.10%
|
2014 Q2
|
$0.22
|
2.10%
|
2014 Q1
|
$0.22
|
2.40%
|
2013 Q4
|
$0.22
|
2.30%
|
2013 Q3
|
$0.14
|
1.70%
|
2013 Q2
|
$0.14
|
1.60%
|
2013 Q1
|
$0.14
|
1.50%
|
2012 Q4
|
$0.54
|
6.50%
|
2012 Q3
|
$0.51
|
2.90%
|
2012 Q2
|
$0.51
|
3.10%
|
2012 Q1
|
$0.51
|
3.40%
|
2011 Q4
|
$0.48
|
1.70%
|
2011 Q3
|
$0.48
|
1.70%
|
2011 Q2
|
$0.48
|
1.70%
|
|
|